Latest filing published 10 Nov 2022 for Cardlytics, Inc., €23. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Scott D. Grimes on record concern Cardlytics, Inc., in the capacity of chief executive. The record holds 42 filings, for trades running from 31 December 2020 to 8 November 2022.
No open-market purchase appears, only 35 sales worth €3.7M. Outside the open market, there are 1 share grant and 5 option exercises. 2022 to date brings no purchases and 11 sales.
The record was last updated on 10 November 2022 with an open-market sale (€23) in Cardlytics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations